Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression: A secondary analysis of data from the PREVENT study.
International Clinical Psychopharmacology.
Times cited: 11
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the Acute and Continuation Phases.
Times cited: 29